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erald S. Berenson, MD, FACC,‡ James H. Stein, MD, FACC*
adison, Wisconsin; Durham and Winston-Salem, North Carolina; and New Orleans, Louisiana
OBJECTIVES The purpose of this study was to investigate the association of metabolic syndrome (MetS)
with subclinical atherosclerosis, determined by ultrasound carotid intima-media thickness
(CIMT) measurements, in young adults.
BACKGROUND Metabolic syndrome is associated with subclinical atherosclerosis and increased cardiovascular
risk in older and middle-aged adults; however, these associations have not been studied
among young adults.
METHODS Non-diabetic subjects from Bogalusa Heart Study, a longitudinal study of atherosclerosis in
young adults, underwent B-mode ultrasonography of the carotid arteries. Metabolic syn-
drome was defined with the National Cholesterol Education Program Adult Treatment Panel
III (MetSNCEP) and World Health Organization (MetSWHO) definitions. CIMT and MetS
associations were evaluated with multivariable regression and area under receiver-operator
characteristic curve (AUC) analyses.
RESULTS Of 507 subjects (29% black, 39% male, mean [SD] age 32 [3] years), 67 (13%) had
MetSNCEP and 65 (13%) had MetSWHO. Common (mean  0.70 [0.11] mm vs. 0.66 [0.08]
mm, p  0.002) and internal CIMT (0.72 [0.21] mm vs. 0.68 [0.12] mm, p  0.020) were
higher among those with MetSNCEP than those without MetSNCEP. Common (0.69 [0.11]
mm vs. 0.66 [0.08] mm, p 0.020) and internal CIMT (0.73 [0.23] mm vs. 0.68 [0.12] mm,
p  0.012) also were higher among those with MetSWHO than those without MetSWHO.
Composite CIMT increased with the number of MetS components present (MetSNCEP r 
0.997, p  0.001; MetSWHO r  0.946, p  0.053). Metabolic syndromeNCEP (AUC 
0.557, 95% confidence interval [CI] 0.513 to 0.601) and MetSWHO (AUC  0.539, 95% CI
0.495 to 0.584) both predicted composite CIMT 75th percentile.
CONCLUSIONS In young adults, MetS is associated with increased atherosclerotic burden, and therefore,
increased cardiovascular risk. These results support the importance of screening and early
intervention in this population. (J Am Coll Cardiol 2005;46:457–63) © 2005 by the
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.04.046American College of Cardiology Foundation
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ihe Third National Health and Nutrition Examination Sur-
ey recently reported a 24% prevalence of metabolic syndrome
MetS) in the U.S., accounting for an estimated 47 million
ffected individuals in 2000 (1). Those affected have insulin
esistance with metabolic abnormalities that place them at
ncreased risk for cardiovascular disease and increased mor-
From the *Atherosclerosis Imaging Research Program, Section of Cardiovascular
edicine, University Medical School, Madison, Wisconsin; †Division of Cardiovas-
ular Medicine, Duke University Medical Center, Durham, North Carolina; ‡Tulane
enter for Cardiovascular Health and Department of Epidemiology, Tulane Univer-
ity Health Sciences Center, New Orleans, Louisiana; and the §Division of Vascular
ltrasound Research, Wake Forest University School of Medicine, Winston-Salem,
orth Carolina. This study was funded in part by the National Center for Research
esources (RR-1617601), the National Heart, Lung, and Blood Institute (HL-38844
nd HL-07936), the National Institute on Aging (AG-16592), the National Institute
f Child Health and Human Development (HD-043820), and the American Heart
ssociation (0160261B). Dr. Stein has received research grants from Siemens
edical Solutions, Camtronics Medical Systems, and Sonosite, all ultrasound
quipment vendors. He previously served as a consultant to Sonosite.s
Manuscript received February 9, 2005; revised manuscript received March 30,
005, accepted April 13, 2005.ality (2–5). In asymptomatic middle-aged adults, MetS also
s associated with accelerated atherosclerosis (6).
Although several studies have associated the presence of
therosclerosis risk factors with subclinical atherosclerosis in
ounger adults, no study has specifically evaluated MetS and
therosclerosis in young adults, a population that increas-
ngly is becoming more overweight (7–12). Finding evi-
ence of an increased burden of subclinical and potentially
eversible vascular disease in young adults would emphasize
he need for heightened awareness and early treatment of
etS. Additionally, comparing available definitions from
he World Health Organization (MetSWHO) and the Na-
ional Cholesterol Education Program Adult Treatment
anel III (MetSNCEP) (13,14) might help determine the
elative utility of diagnostic criteria in this age group.
Carotid intima-media thickness (CIMT), a validated
ethod for detecting subclinical atherosclerosis and predict-
ng cardiovascular risk, was used to investigate the relation-
hips between MetS and subclinical atherosclerosis in
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Metabolic Syndrome and Carotid IMT in Young Adults August 2, 2005:457–63symptomatic young adults from the Bogalusa Heart Study,
pplying and comparing both MetSNCEP and MetSWHO
efinitions (13–15).
ETHODS
ubjects and study design. The institutional review boards
f the Tulane University Health Sciences Center and the
niversity of Wisconsin approved this study. Participants
rovided written informed consent. The Bogalusa Heart
tudy is a longitudinal epidemiological study of the natural
istory of atherosclerosis in children and young adults in
ogalusa, Louisiana (7,11). Detailed study methods and
escriptions have been described previously (7,11,16).
riefly, a subgroup of 519 subjects who were 20 to 38 years
ld (mean age 32 years; 29% black, 71% white; 39% men)
nderwent B-mode ultrasonography of the carotid arteries
uring the 1995 to 1996 survey (7,11). These subjects were
imilar to the total population (N 1,420) in regard to race
p  0.92), gender (p  0.72), body mass index (BMI, p 
.92), systolic blood pressure (SBP, p  0.20), high-density
ipoprotein cholesterol (HDL-C, p  0.80), low-density
ipoprotein cholesterol (LDL-C, p  0.52), and triglycer-
des (p  0.26), but, on average, were approximately four
ears older (p  0.001) (7,11,16). In this study, subjects
ith diabetes mellitus (screening glucose 126 mg/dl or
aking antiglycemic medications) or missing data necessary
o determine diabetes status were excluded from further
nalysis (n  12). All of the remaining 507 subjects were
nalyzed for the presence of MetSNCEP and then, in
eparate analysis, for MetSWHO.
tudy procedures. Study procedure protocols have been
escribed previously (11). Subjects fasted for at least 12 h
efore assessments. Height and weight were measured in
uplicate and averaged to calculate BMI. Waist circumfer-
nce was measured midway between the rib cage and
uperior border of the iliac crest. Blood pressure (BP) was
easured in triplicate in the right arm in a seated, relaxed
osition. Serum lipids were measured with a Technicon
uto Analyzer II (Technicon Instrument, Tarrytown, New
Abbreviations and Acronyms
AUC  area under receiver-operator characteristic
curve
BMI  body mass index
BP  blood pressure
CI  confidence interval
CIMT  carotid intima-media thickness
HDL-C high-density lipoprotein cholesterol
ICA  internal carotid artery
LDL-C  low-density lipoprotein cholesterol
MetS  metabolic syndrome
NCEP  National Cholesterol Education Program
OR  odds ratio
SBP  systolic blood pressure
WHO  World Health Organizationork) with the standardized procedures of the Lipid Re- pearch Clinics Program (17). Plasma insulin levels were
easured by radioimmunoassay (Phaadebas Insulin Kit,
harmacia Diagnostics AB, Portage, Michigan). Plasma
lucose was measured on a Beckman glucose analyzer by the
lucose oxidase method.
arotid ultrasonography. Images of common carotid, ca-
otid bulb, and internal carotid artery (ICA) segments were
ecorded with a Toshiba Sonolayer SSH 160A (Toshiba
edical, Tustin, California) and a 7.5-MHz linear array
ransducer (11). Carotid artery segments were interrogated
nd measured with previously developed protocols for the
therosclerosis Risk in Communities study (18). Certified
eaders conducted measurements with a semi-automated
easurement program, as previously described (7). Mean
alues of three right and three left far-wall measurements
ere calculated separately for each of the three bilateral
arotid segments. Right and left measurements for common
arotid, carotid bulb, and ICA segments were averaged to
reate segmental and overall composite values.
efinition of MetS. Metabolic syndromeNCEP was iden-
ified when three of the following five criteria were present:
) waist circumference 102 cm in men or 88 cm in
omen; 2) triglycerides 150 mg/dl; 3) HDL-C 40
g/dl in men or 50 mg/dl in women; 4) BP 130/85
m Hg or on antihypertensive medication; 5) fasting
lucose 110 mg/dl (14). Metabolic syndromeWHO was
dentified if: 1) the insulin level was greater than the upper
uartile of the study population or fasting plasma glucose
110 mg/dl; and 2) at least two of the following were
resent: a) BMI 30 kg/m2; b) serum triglycerides 150
g/dl or HDL-C 35 mg/dl for men or 40 mg/dl for
omen; and c) BP 140/90 mm Hg or on BP medication
5,13). The latter criteria were modified from the original
999 MetSWHO definition and recently were shown to
ccurately predict incident diabetes mellitus (19,20).
tatistical analysis. Statistical analyses were performed
ith the SAS system (SAS Institute, Cary, North Carolina).
wo-tailed Student t tests were performed to compare
ontinuously distributed variables (age, glucose, insulin,
ipids, waist girth, BMI, weight, SBP, diastolic BP, and
IMT) between genders and races and to compare CIMT
easurements between individuals with and without MetS.
xact binomial analysis was used to compare binomial
ariables (presence of MetS, hypertension, hyperlipidemia,
moking, family history) (21). To correct for potentially
ncreased type I error rates with multiple testing, the
enjamini and Hochberg (22) false discovery rate adjust-
ent was performed.
Unadjusted odds ratios (ORs) with 95% confidence
ntervals (CIs) and p values for trends of increasing MetS
revalence among increasing CIMT quintiles were formu-
ated from Cochran-Armitage trend test models, in which
IMT quintiles were the independent variables. Subse-
uent adjustments for age and gender and then age, gender,
ace, and smoking were made to formulate adjusted OR andvalues. Linear regression was used to assess the relation-
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August 2, 2005:457–63 Metabolic Syndrome and Carotid IMT in Young Adultship between number of MetS components and increasing
IMT. Multiple regression analyses with the general linear
odel were used to ascertain the relative impact of each
omponent of MetS on increased CIMT. Finally, two
rea under receiver-operator characteristic curves (AUC)
ere generated, with composite CIMT 75th percentile
s the dependent variable, and the presence of MetSNCEP
nd MetSWHO as independent variables in respective
odels. Models were then compared after deriving 95%
Is (23).
ESULTS
aseline characteristics. Characteristics of the 507 non-
iabetic subjects who underwent carotid ultrasonography
re summarized in Table 1. Men had significantly higher
erum glucose, LDL-C, SBP, and diastolic BP, greater
aist circumference, and lower HDL-C than women. Men
ad a lower rate of reporting a family history of coronary
rtery disease. All CIMT measurements were significantly
igher in men than in women, except for the ICA, which
nly tended to be higher (Table 1). Black subjects had
igher HDL-C, SBP, diastolic BP, and composite and
ommon carotid artery CIMT measurements, and lower
otal cholesterol and LDL-C than white subjects. Black
ubjects also were more likely to be current cigarette
mokers. No significant differences between genders or races
ere seen in regard to age or BMI. Only 26 subjects used
ntihypertensive medications; black men were most likely to
se these medications (p  0.001).
MetSNCEP was present in 67 (13%) subjects, and
able 1. Baseline Characteristics
White
Men
ge (yrs) 32 (3)
lucose (mg/dl) 81 (9)
nsulin (U/ml) 12 (7)
ipids (mg/dl)
Total cholesterol 204 (43)
Triglycerides 137 (96)
High-density lipoprotein cholesterol 42 (10)
Low-density lipoprotein cholesterol 137 (33)
ystolic blood pressure (mm Hg) 115 (11)
iastolic blood pressure (mm Hg) 77 (9)
aist circumference (cm) 95 (13)
ody mass index (kg/m2) 28 (5)
IMT (mm)
Composite 0.76 (0.12) 0
Common carotid artery 0.67 (0.09) 0
Bulb 0.91 (0.22) 0
Internal carotid artery 0.71 (0.14) 0
ypertension, n (%) 7 (5)
urrent smoker, n (%) 45 (32)
amily history of coronary artery disease, n (%) 84 (59)
etabolic syndrome, n (%)
NCEP 22 (16)
WHO 17 (12)ll values expressed as mean (SD), unless otherwise noted; all p values are adjusted for mu
CIMT  carotid intima-media thickness; NCEP  National Cholesterol Education PetSWHO was present in 65 (13%) subjects. There were no
ignificant differences in the prevalence of MetS by either
efinition among genders or races (Table 1). Ninety-five
ubjects were classified as having either MetSNCEP or
etSWHO; however only 37 (39%) met criteria for both. Of
he 95, 28 (29%) only met criteria for MetSWHO and 30
32%) only met criteria for MetSNCEP. Subjects with
etSWHO and MetSNCEP did not differ significantly in
nthropometric, hemodynamic, or metabolic characteristics
Table 2), although those with MetSNCEP tended to have
maller waist circumference, lower BMI, and a higher
roportion of smokers and treated hypertensives than those
ith MetSWHO.
arotid wall thickness and MetS. Composite and all
egmental CIMT values were significantly higher among
hose with MetSNCEP than those without (Table 3). Com-
on and ICA CIMT also were significantly higher among
hose with MetSWHO, but composite and bulb CIMT
alues were not.
The prevalence of MetSNCEP increased significantly
ver quintiles of composite, common carotid artery, and
ulb CIMT (Table 4). These relationships remained
ignificant even after adjusting for age, gender, race, and
urrent smoking. For MetSWHO, increasing common
arotid artery CIMT also was associated with increasing
dds of having MetS (adjusted OR 2.5, 95% CI 1.1 to
.6, p  0.025). Similar trends were observed for the
CA (adjusted OR 1.8, 95% CI 0.8 to 4.2, p  0.151),
ut not for the bulb, so the association between preva-
ence of MetSWHO and increasing composite CIMT was
Black
padj
(Gender)
padj
(Race)en Men Women
3) 32 (3) 32 (2) 0.247 0.464
8) 80 (9) 77 (10) 0.006 0.475
7) 12 (9) 15 (21) 0.190 0.087
39) 189 (52) 183 (34) 0.071 0.013
163) 119 (123) 83 (45) 0.093 0.068
13) 52 (23) 57 (16) 0.006 0.006
32) 120 (48) 114 (29) 0.006 0.006
11) 119 (12) 115 (15) 0.006 0.006
9) 78 (10) 76 (11) 0.006 0.087
14) 90 (18) 89 (17) 0.006 0.542
7) 27 (7) 30 (8) 0.277 0.120
0.09) 0.76 (0.10) 0.75 (0.09) 0.008 0.073
0.08) 0.71 (0.09) 0.69 (0.09) 0.024 0.006
0.14) 0.89 (0.18) 0.89 (0.16) 0.017 0.136
0.14) 0.71 (0.12) 0.69 (0.11) 0.056 0.464
3) 6 (10) 7 (8) 0.330 0.073
30) 35 (56) 35 (40) 0.198 0.006
73) 31 (49) 59 (68) 0.008 0.136
13) 7 (11) 9 (11) 0.568 0.464
13) 9 (14) 11 (14) 0.989 0.648Wom
32 (
77 (
11 (
193 (
124 (
52 (
122 (
108 (
73 (
82 (
27 (
.71 (
.64 (
.81 (
.66 (
6 (
68 (
166 (
29 (
28 (ltiple testing.
rogram; WHO  World Health Organization.
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Metabolic Syndrome and Carotid IMT in Young Adults August 2, 2005:457–63ot statistically significant. Nevertheless, the ability of
etSNCEP and MetSWHO to predict composite CIMT
75th percentile did not differ significantly (MetSNCEP
UC  0.557 [95% CI 0.513 to 0.601] vs. 0.539 [95%
I 0.495 to 0.584] for MetSWHO).
As shown in Figure 1, there was a direct relationship
etween the number of MetSNCEP components and increas-
ng composite CIMT (r  0.997, p  0.001). A similar
rend was observed between number of MetSWHO compo-
ents and composite CIMT (r  0.946, p  0.053). The
esults of the multiple regression analyses that evaluated the
ndependent and related effects of components of
etSNCEP on composite CIMT are shown in Table 5 (F
.385, p  0.001). Increased BP was most predictive of
ncreased composite CIMT, followed by low HDL-C.
levated triglycerides, serum glucose, and abdominal adi-
osity did not independently significantly predict increased
omposite CIMT. Similarly, with WHO criteria, presence
f elevated triglycerides or low HDL-C most strongly
redicted increased composite CIMT (F  4.550, p 
.001). Very similar results were obtained after excluding
he 26 subjects receiving antihypertensive medication (data
ot shown).
ISCUSSION
n this population of asymptomatic young adults, MetS,
efined by either NCEP ATP III or WHO guidelines, was
ssociated with increased common and internal CIMT;
Table 2. Characteristics of Subjects With Met
WHO Criteria
Age (yrs)
Men (%)
White race (%)
Systolic blood pressure (mm Hg)
Diastolic blood pressure (mm Hg)
Glucose (mg/dl)
Waist circumference (cm)
Body mass index (kg/m2)
Total cholesterol (mg/dl)
High-density lipoprotein cholesterol (mg/dl)
Low-density lipoprotein cholesterol (mg/dl)
Triglycerides (mg/dl)
Current smokers (%)
Antihypertensive medication (%)
All values expressed as mean (SD), unless otherwise noted;
Abbreviations as in Table 1.
able 3. Carotid Intima-Media Thickness Values Among Subjec
NCEP Definition
MetS Present MetS Absent
omposite 0.78 (0.13) 0.73 (0.10)
Common carotid artery 0.70 (0.11) 0.66 (0.08)
Bulb 0.92 (0.21) 0.85 (0.17)
Internal carotid artery 0.72 (0.21) 0.68 (0.12)ll values expressed as mean (SD) mm, unless otherwise noted; all p values are adjusted fo
MetS  metabolic syndrome; other abbreviations as in Table 1.etSNCEP also was associated with increased bulb and
omposite CIMT. These findings indicate an increased
urden of subclinical atherosclerosis and suggest an in-
reased risk of future cardiovascular events in young adults
ith MetS. As CIMT increased, the prevalence of MetS
lso increased, culminating in nearly a 2.5-fold increased
ikelihood of MetS in the highest quintile of common
IMT and a 3.4-fold increased likelihood of MetSNCEP in
he highest composite CIMT quintile. The strengths of
hese relationships were maintained even after adjusting for
ge, gender, race, and current smoking. Regression analysis
orroborated the strength of these associations by showing
hat increasing numbers of MetS components were directly
ssociated with higher composite CIMT. Of the MetSNCEP
omponents, increased BP and low HDL-C independently
redicted increased CIMT; of MetSWHO components, high
riglycerides or low HDL-C were most predictive. Both
CEP and WHO definitions identified those with more
dvanced subclinical atherosclerosis equally well.
Studies in middle-aged and older adults have demon-
trated that MetS predicts cardiovascular disease and mor-
ality. The Botnia Study, for instance, demonstrated that
iddle-aged adults with MetS have an approximately three-
old increased risk of incident coronary heart disease and
ore than a two-fold increased risk of stroke (4). A
ompelling finding was that the risk of coronary heart
isease morbidity associated with MetS exceeded that asso-
iated with its individual components, suggesting that
c Syndrome by NCEP Compared with
NCEP WHO padj
32 (2) 32 (3) 0.807
43 40 0.851
76 69 0.807
123 (14) 121 (13) 0.807
84 (9) 82 (10) 0.807
83 (10) 84 (11) 0.851
103 (10) 107 (13) 0.452
34 (5) 37 (7) 0.165
211 (53) 208 (56) 0.851
36 (10) 38 (11) 0.807
126 (37) 127 (35) 0.875
265 (282) 221 (276) 0.807
31 23 0.807
19 15 0.851
alues are adjusted for multiple testing.
ith and Without Metabolic Syndrome
WHO Definition
padj MetS Present MetS Absent padj
0.002 0.76 (0.14) 0.73 (0.10) 0.125
0.002 0.69 (0.11) 0.66 (0.08) 0.020
0.005 0.88 (0.22) 0.86 (0.18) 0.399
0.020 0.73 (0.23) 0.68 (0.12) 0.012abolits Wr multiple testing.
i
t
p
i
T
i
i
a
a
t
a
1
s
a
h
a
a
A
3
C
B
a
w
c
a
s
o
c
T
C
C
B
I
*
F
c
E
461JACC Vol. 46, No. 3, 2005 Tzou et al.
August 2, 2005:457–63 Metabolic Syndrome and Carotid IMT in Young Adultsndividuals with the constellation of metabolic abnormali-
ies that characterize MetS should be targeted for aggressive
rimary prevention. Additionally, increased BP and dyslip-
demia were the strongest predictors of vascular events (4).
he present study demonstrated that the risk associations
dentified with MetS in middle-aged adults also are operant
n young, asymptomatic adults.
able 4. Prevalence of Metabolic Syndrome* and Carotid Intima
CIMT Quintiles
n
(% MetS) Un
omposite (mm)
0.66 79 (10.1)
0.67–0.70 60 (15.0) 1.30
0.71–0.74 68 (14.7) 1.69
0.75–0.79 54 (11.1) 2.21
0.80 70 (28.6) 2.88
ptrend
ommon carotid artery (mm)
0.59 102 (10.8)
0.60–0.63 91 (11.0) 1.24
0.64–0.67 110 (8.2) 1.55
0.68–0.73 92 (17.4) 1.94
0.74 93 (20.4) 2.42
ptrend
ulb (mm)
0.72 94 (11.7)
0.73–0.80 85 (9.4) 1.24
0.81–0.87 78 (16.7) 1.53
0.88–0.97 96 (9.4) 1.90
0.98 87 (25.3) 2.36
ptrend
nternal carotid artery (mm)
0.58 79 (12.7)
0.59–0.64 95 (12.6) 1.15
0.65–0.69 78 (11.5) 1.32
0.70–0.76 82 (17.1) 1.53
0.77 78 (19.2) 1.76
ptrend
National Cholesterol Education Program definition.
CI  confidence interval; other abbreviations as in Tables 1 and 3.
igure 1. Effect of the number of components of metabolic syndrome* oni
omposite carotid intima-media thickness (CIMT). *National Cholesterol
ducation Program definition.To date, no studies have been published that specifically
ddressed the relationship between MetS and subclinical
therosclerosis in young adults, although associations be-
ween CIMT and atherosclerosis risk factors, some of which
re MetS components, have been described (7–9,11,
2,16,24,25). Recent reports indicated that the presence of
uch components in childhood are associated with increased
dult CIMT (11,12). In the Bogalusa Heart Study, child-
ood BMI was one of the strongest predictors of increased
dult CIMT (11), whereas in the Young Finns study, BMI
nd SBP predicted increased adult CIMT (12). In the
therosclerosis Risk in Young Adults study of white 27- to
0-year-olds, BMI predicted common carotid artery
IMT; however, after adjustment for age, gender, and
MI, components of the MetS such as BP, triglycerides,
nd waist/hip ratio, did not predict CIMT (9). This study
as limited because CIMT was measured only in the
ommon carotid artery, a segment that usually lags the bulb
nd ICA in the development of atherosclerosis (9,26).
In the Atherosclerosis Risk Factors in Male Youngsters
tudy of 17- to 18-year-old white men, MetS components
f elevated diastolic BP and low HDL-C predicted in-
reased CIMT (10). Body mass index was not higher in
ia Thickness
Odds Ratio (95% CI)
sted
Adjusted for
Age and Gender
Adjusted for Age,
Gender, Race, and
Smoking Status
1.00 1.00
–1.60) 1.29 (1.04–1.60) 1.35 (1.08–1.69)
–2.57) 1.67 (1.08–2.57) 1.83 (1.16–2.88)
–4.12) 2.16 (1.12–4.13) 2.48 (1.26–4.89)
–6.61) 2.79 (1.17–6.63) 3.37 (1.36–8.31)
2 0.020 0.008
1.00 1.00
–1.50) 1.21 (0.99–1.47) 1.25 (1.02–1.53)
–2.27) 1.47 (0.99–2.17) 1.57 (1.05–2.34)
–3.44) 1.78 (0.99–3.20) 1.96 (1.08–3.58)
–5.19) 2.16 (0.99–4.72) 2.46 (1.11–5.49)
2 0.052 0.026
1.00 1.00
–1.50) 1.21 (0.99–1.48) 1.23 (1.01–1.51)
–2.25) 1.48 (0.99–2.21) 1.53 (1.02–2.29)
–3.38) 1.80 (0.98–3.28) 1.89 (1.03–3.48)
–5.08) 2.19 (0.98–4.89) 2.34 (1.04–5.27)
7 0.054 0.039
1.00 1.00
–1.40) 1.12 (0.92–1.37) 1.14 (0.93–1.39)
–1.97) 1.27 (0.85–1.90) 1.30 (0.87–1.94)
–2.76) 1.43 (0.78–2.62) 1.49 (0.81–2.71)
–3.88) 1.92 (0.72–3.62) 1.70 (0.76–3.79)
7 0.235 0.193-Med
adju
1.00
(1.06
(1.12
(1.19
(1.26
0.01
1.00
(1.03
(1.06
(1.09
(1.13
0.02
1.00
(1.02
(1.04
(1.07
(1.10
0.02
1.00
(0.94
(0.89
(0.84
(0.80
0.15ndividuals with increased CIMT; however, this study was
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ass index 22.5 kg/m2) (10). In the Muscatine Study,
ultivariate analysis showed that CIMT was associated with
BP, increasing age, and LDL-C in women and with smoking
n men (27). Significant univariate correlations included BMI
n men only, waist/hip ratio and triglycerides in women, but
ot HDL-C, glucose, or fasting insulin (27). These subjects,
lmost exclusively, were white; more than one-half were men
38 years old, and nearly one-half smoked cigarettes, limiting
he generalizability of these data. On the basis of these
revious studies, the relationships between MetS, MetS
omponents, and CIMT could not be ascertained. Finally,
etS by modified NCEP criteria (using BMI instead of
aist circumference) predicted the presence of coronary
rtery calcium among a population that included individuals
s young as 20 years (adjusted OR 1.40, 95% CI 1.05 to
.87, p 0.02).(28). The mean age (52.7 [9.9] years) of the
ohort, however, was notably older than in our study. Our
tudy is the first to analyze the relationship between MetS as
diagnostic entity and subclinical atherosclerosis in young,
symptomatic adults.
Carotid intima-media thickness values were similar
mong those with MetSNCEP or MetSWHO. The lack of a
ignificant difference in composite CIMT between those
ith and without MetSWHO appears to have been due to
he lack of a significant difference between bulb CIMT
alues, because common and internal carotid CIMT mea-
urements did differ significantly. It is unclear why bulb
IMT was higher among those with MetSNCEP but not
hose in the MetSWHO group. One reason might be that
ulb CIMT images anatomically are more difficult to obtain
nd measurements are more variable than in the common
arotid artery; however, these issues should not have differ-
ntially affected the MetS definitions. Another consider-
tion is that more than one-half of those meeting criteria for
ither MetSNCEP or MetSWHO (61%) were different sub-
ects and those with MetSNCEP tended to include more
mokers and subjects on therapy for hypertension, qualities
hat have been shown to differentially increase bulb CIMT
hickness (29). Despite these differences, trends for increas-
ng composite CIMT were associated with increasing num-
ers of either MetSNCEP or MetSWHO components. Addi-
ionally, both NCEP and WHO criteria identified subjects
Table 5. Components of Metabolic Syndrome*
Regression
Coefficient
Increased blood pressure† 0.053
Low HDL-C‡ 0.030
Glucose 110 mg/dl 0.142
Triglycerides 150 mg/dl 0.011
Abdominal adiposity§ 0.006
*National Cholesterol Education Program definition; †systoli
Hg or use of antihypertensive medication; ‡high-density lip
(women); §waist circumference 102 cm (men) or 88 cmith composite CIMT 75th percentile equally well, thus confirming their clinical value in primary cardiovascular
isease prevention and intervention.
Direct comparisons with previous studies are difficult
ecause of differing definitions of MetS. The WHO was the
rst to specify diagnostic criteria in 1999; however, the
ractical difficulties in meeting some of the criteria, such as
sing the insulin clamp method to measure insulin resis-
ance or assessing impaired glucose tolerance with oral
lucose tolerance testing, have limited the use of the strict
efinition (13). Additionally, inclusion of microalbuminuria
mong the diagnostic criteria has been controversial (19,20).
ubsequent groups have employed modified MetSWHO
efinitions (3–6). The NCEP definition, which was pre-
ented more recently, is based on more easily measurable
omponents; however, it has been criticized for being less
ensitive for detecting insulin resistance, which is associated
ith cardiovascular risk factors in the absence of MetS
30,31). Nevertheless, despite differences in criteria used
etween studies, associations of MetS and increased CIMT
n middle-aged adults have been fairly consistent. For
xample, the Atherosclerosis and Insulin Resistance study
howed that middle-aged white men with MetSWHO had
ncreased CIMT, and the Brunek Study of middle-aged and
lderly adults demonstrated that carotid atherosclerosis was
ignificantly higher in individuals with MetSWHO (using a
odified WHO definition) and MetSNCEP (3,6). Our study
rovides the first analysis of the impact of MetS on the
natomic burden of subclinical atherosclerosis in young,
symptomatic adults. Furthermore, it provides a comparison
f the established definitions of MetS and suggests that
oth sets of criteria are useful for detecting subclinical
therosclerosis in this age group. This is an important area
f interest, especially given the increasing prevalence of
hildhood obesity, insulin resistance, and predicted cardio-
ascular risk (32).
onclusions. Identification of MetS in young, otherwise
ealthy adults is an important marker of increased subclin-
cal atherosclerosis and, therefore, increased cardiovascular
isk. The burden of subclinical atherosclerosis in young
dults increases with an increasing burden of components of
etS, and increased BP and low HDL-C are especially
owerful predictors of increased CIMT. Both NCEP and
HO definitions identify those with more advanced sub-
redictors of Carotid Intima-Media Thickness
Standard
Error
Standardized
Coefficient p Value
0.013 0.199 0.001
0.010 0.145 0.006
0.103 0.070 0.168
0.014 0.043 0.411
0.012 0.025 0.622
pressure130 mm Hg or diastolic blood pressure85 mm
in cholesterol (HDL-C) 40 mg/dl (men) or 50 mg/dl
en).as P
c bloodlinical atherosclerosis equally well. Because MetS charac-
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odifiable, they might be appropriate targets for interven-
ion in young adults.
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